AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
Condition: Myocarditis Intervention: Drug: Abatacept 250 MG Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2022 Category: Research Source Type: clinical trials
Expanded Access for Abatacept
Condition: Intervention: Biological: Abatacept Sponsor: Bristol-Myers Squibb Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2021 Category: Research Source Type: clinical trials